Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?

Pediatric Blood and Cancer

Volumn 57, Issue 1, 2011, Pages 8-9

  Segel, George B ^a   Simon, William ^a   Lichtman, Marshall A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

BLOOD TRANSFUSION; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; NOTE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STAINING;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE COUNT; ERYTHROCYTES, ABNORMAL; FETAL HEMOGLOBIN; HUMANS; HYDROXYUREA; INFANT; YOUNG ADULT;

EID: 79955711089     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23128     Document Type: Note

References (9)

1. Benesch RE, Edalji R, Benesch R, et al. Solubilization of hemoglobin S by other hemoglobins. Proc Natl Acad Sci USA 1980; 77: 5130-5134.
2. Meier ER, Byrnes C, Weissman M, et al. Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood. Pediatr Blood Cancer 2011; 56: 103-109.
3. Hulbert ML, McKinstry RC, Lacey JL, et al. Silent cerebral infarcts occur despite regular blood transfusion therapy after first stroke in children with sickle cell disease. Blood 2010 Oct 12 [Epub ahead of print].
4. Bunn HF. Induction of fetal hemoglobin in sickle cell disease. Blood 1999; 93: 1787-1789.
5. Turhan A, Weiss LA, Mohandas N, et al. Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm. Proc Natl Acad Sci USA 2002; 99: 3047-3051.
6. Johnson C, Telen MJ. Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease. Haematologica 2008; 93: 481-485.
7. Segel GB, Halterman MW, Lichtman MA. The paradox of the neutrophil's role in tissue injury: A review. J Leukoc Biol 2011; 89: 359-372.
8. Ma Q, Wyszynski DF, Farrell JJ, et al. Fetal hemoglobin in sickle cell anemia: Genetic determinants of response to hydroxyurea. Pharmacogenomics J 2007; 7: 386-394.
9. Steinberg MH, Voskaridou E, Kutlar A, et al. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease. Am J Hematol 2003; 72: 121-126.